Citi just downgraded $MRNA to Sell, saying the rally is no longer justified. Moderna is up 222%+ since last August. Biotech peers are down 2%. Citi's price target is $60. Even in ideal scenarios, it values the stock at $100. To justify $200, Moderna would need $26B in annual oncology sales. Seeking Alpha Quant Rating: Hold, supported by strong momentum. The bull case rests on the personalized cancer vaccine with Merck beating expectations 7x over. Is this rally priced for perfection? ▻
published
Citi just downgraded $MRNA to Sell, saying the rally is no longer justified. Moderna is up 222%+ since last August. Biotech peers are down 2%. Citi's price target is $60. Even in ideal scenarios, it values the stock at $100. To justify $200, Moderna would need
$MRNA
Open the original public source →
Latest documented BWB result
$NCPL · $GCDT · $SUNE market result
Here is my September recap 💥 Entry top percentage of move For sure i didn’t hold the full move on all of them, and for sure i got hit with a lot of losses, but i always manage to have a plan, stick to it, minimize losse…
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.